Monday, January 21, 2013
FDA recommends lower dose of Ambien for women
This article discusses recent news release that the FDA is lowering its recommended dosage of Zolpidem in women. Zolpidem is active ingredient in Ambien. FDA says women can not metabolize the medicine at full strength quick enough, and still have high levels in their bloodstream when waking in the morning. This could lead to motor vehicle accidents. The FDA is not saying women on full strength Ambien have to have their dose reduced, or that women will not be allowed to take full strength. Just that these patients on Ambien should give themselves plenty of time in bed so that the medicine is fully metabolized and they are safe to drive.